Patient Navigation in Amyotrophic Lateral Sclerosis (ALS): A Potential Approach to Timely Diagnosis

被引:0
|
作者
Mombaur, Busisiwe [1 ]
Dias, Kaiseree [2 ]
机构
[1] Columbia Univ, Neurol Inst, 710 West 168th St, New York, NY 10032 USA
[2] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Bristol, England
关键词
Patient navigation; amyotrophic lateral sclerosis; delayed diagnosis; ALS; CANCER CARE; DISEASE; HEALTH; IMPACT;
D O I
10.1353/hpu.2025.a951602
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) poses challenges for timely diagnosis due to its protean early manifestations and lack of definitive tests. This article explores how patient navigation interventions can expedite diagnosis, particularly for underserved patients who face disproportionately longer delays. Patient navigation has proven effective in reducing disparities in various diseases by providing guidance and support to patients and caregivers. It enhances awareness, facilitates communication with health care providers, and streamlines diagnosis. Drawing from literature on patient navigation in other diseases, this article proposes tailored adaptations for ALS diagnosis and addresses potential implementation barriers and strategies to overcome them. Integrating patient navigation into the ALS diagnostic pathway holds promise for improving efficiency, optimizing outcomes, and reducing health care disparities among underserved populations.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Correlates of suffering in amyotrophic lateral sclerosis (ALS)
    Ganzini, L
    Johnston, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S10 - S10
  • [42] Motoneuron firing in amyotrophic lateral sclerosis (ALS)
    de Carvalho, Mamede
    Eisen, Andrew
    Krieger, Charles
    Swash, Michael
    FRONTIERS IN HUMAN NEUROSCIENCE, 2014, 8
  • [43] AN IMMUNOLOGICAL PROFILE OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    MALIN, JP
    NERVENARZT, 1990, 61 (02): : 105 - 111
  • [44] Diagnosing amyotrophic lateral sclerosis (ALS) in ENT
    Harrison, L.
    Wills, A.
    Beasley, N.
    CLINICAL OTOLARYNGOLOGY, 2013, 38 (06) : 564 - 565
  • [45] Lead exposure and amyotrophic lateral sclerosis (ALS).
    Kamel, F
    Umbach, DM
    Hu, H
    Munsat, TL
    Shefner, JM
    Sandler, DP
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S75 - S75
  • [46] LINKAGE IN FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    SIDDIQUE, T
    PERICAKVANCE, MA
    BROOKS, BR
    BIAS, W
    WALKER, N
    SIDDIQUE, N
    HUNG, WY
    ROSES, AD
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 692 - 692
  • [47] Drug repurposing in amyotrophic lateral sclerosis (ALS)
    Carroll, Emily
    Scaber, Jakub
    Huber, Kilian V. M.
    Brennan, Paul E.
    Thompson, Alexander G.
    Turner, Martin R.
    Talbot, Kevin
    EXPERT OPINION ON DRUG DISCOVERY, 2025,
  • [48] Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
    Sebastiao, Ana M.
    Rei, Nadia
    Ribeiro, Joaquim A.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [49] ADVANCES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
    Andreadou, E.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3197 - 3198
  • [50] Diagnostic biomarkers for amyotrophic lateral sclerosis (ALS)
    Bowser, R
    Ranganathan, S
    Ganchev, P
    Gopalakrishnan, V
    Cudkowicz, M
    Brown, RH
    FASEB JOURNAL, 2005, 19 (05): : A1511 - A1511